| ADMET | Absorption, Distribution, Metabolism, Excretion, and Toxicity |
| AI | Artificial Intelligence |
| AUC | Area Under the Curve |
| BC | Breast Cancer |
| BMI | Body Mass Index |
| CADD | Computer-Aided Drug Design |
| CDER | Center for Drug Evaluation and Research |
| CDK | Cyclin-Dependent Kinase |
| CGRP | Calcitonin Gene-Related Peptide |
| CMap | Connectivity Map |
| EGFR | Epidermal Growth Factor Receptor |
| EHR | Electronic Health Record |
| ERs | Estrogen Receptors |
| ERK | Extracellular Signal-Regulated Kinase |
| FDA | The United States Food and Drug Administration |
| FOXM1 | Forkhead Box M1 |
| FZD | Frizzled Receptor |
| GNN | Graph Neural Network |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HR | Homologous recombination |
| LINCS | The Library of Integrated Network-Based Cellular Signatures |
| MAPK | Mitogen-Activated Protein Kinase |
| MCF-7 | Michigan Cancer Foundation-7 |
| MDA-MB-231 | MD Anderson Metastatic Breast 231 |
| ML | Machine Learning |
| MLP | Multi-Layer Perceptron |
| mTOR | The Mammalian Target of Rapamycin |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NF-κB | Nuclear Factor kappa B |
| NLP | Natural Language Processing |
| NMF-DR | Non-Negative Matrix Factorization-based Drug Repurposing |
| PD-L1 | Programmed Death-Ligand 1 |
| PDPK1 | Phosphoinositide-Dependent Kinase-1 |
| PRs | Progesterone Receptors |
| QSAR | Quantitative Structure–Activity Relationship |
| ROC | Receiver Operating Characteristic |
| RWD | Real World Data |
| SERD | Selective Estrogen Receptor Degrader |
| SERM | Selective Estrogen Receptor Modulator |
| STITCH | Search Tool for Interactions of Chemicals |
| SUM149 | Stephen University Mammalian cell line #149 |
| TCGA | The Cancer Genome Atlas |
| TNBC | Triple-Negative Breast Cancer |